---
figid: PMC7352686__ijms-21-04405-g002
figtitle: Complex I mutations
organisms:
- Mus musculus
- Rattus norvegicus
- Fusobacterium nucleatum
- Akkermansia muciniphila
- Homo sapiens
- gut metagenome
- Adeno-associated virus
- Ustilago maydis
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7352686
filename: ijms-21-04405-g002.jpg
figlink: pmc/articles/PMC7352686/figure/ijms-21-04405-f002/
number: F2
caption: Effects of complex I mutations. (1) As a result of complete loss of complex
  I, NADH inhibits the TCA cycle enzyme α-ketoglutarate dehydrogenase (αKGDH). This
  increases α-ketoglutarate levels and results in HIF1α inhibition. (2–4) Complex
  I mutations increase reactive oxygen species (ROS) production. (2) ROS activate
  pyruvate dehydrogenase kinase (PDK2), which inhibits pyruvate dehydrogenase (PDH).
  Pyruvate accumulation activates HIF1α. (3) ROS activate the phosphatidylinositol
  3-kinase (PI3K)/protein kinase B (AKT)/hypoxia-inducible factor 1 alpha (HIF1α)
  signaling pathway. (4) Mitochondrial ROS activate the NADPH oxidase, which produces
  cytoplasmic superoxide. ROS lead to genomic instability via double-strand breaks
  (DSBs) and activate the cellular anti-oxidant responses.
papertitle: Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic
  Diseases and Cancer.
reftext: Jean Nakhle, et al. Int J Mol Sci. 2020 Jun;21(12):4405.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.954553
figid_alias: PMC7352686__F2
figtype: Figure
redirect_from: /figures/PMC7352686__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7352686__ijms-21-04405-g002.html
  '@type': Dataset
  description: Effects of complex I mutations. (1) As a result of complete loss of
    complex I, NADH inhibits the TCA cycle enzyme α-ketoglutarate dehydrogenase (αKGDH).
    This increases α-ketoglutarate levels and results in HIF1α inhibition. (2–4) Complex
    I mutations increase reactive oxygen species (ROS) production. (2) ROS activate
    pyruvate dehydrogenase kinase (PDK2), which inhibits pyruvate dehydrogenase (PDH).
    Pyruvate accumulation activates HIF1α. (3) ROS activate the phosphatidylinositol
    3-kinase (PI3K)/protein kinase B (AKT)/hypoxia-inducible factor 1 alpha (HIF1α)
    signaling pathway. (4) Mitochondrial ROS activate the NADPH oxidase, which produces
    cytoplasmic superoxide. ROS lead to genomic instability via double-strand breaks
    (DSBs) and activate the cellular anti-oxidant responses.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYBA
  - CYBB
  - DUOX1
  - DUOX2
  - NCF1
  - NCF2
  - NCF4
  - NOX1
  - NOX3
  - NOX4
  - NOX5
  - RAC1
  - DECR1
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - OGDH
  - PDK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - HIF1A
  - SETD2
  - ARNT
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - CycE
  - cyc
  - cv
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Cat
  - tgo
  - sima
  - Glucose
  - NADPH
  - NADP
  - Lactate
  - Pyruvate
  - Acetyl-CoA
  - Succinyl
  - TSA
  - NADH
  - Glutathione
  - Superoxide
---
